NCT03830957

Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

Randomized Clinical Trial of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Rajaie Cardiovascular Medical and Research Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.

Conditions

• Heart Failure
• CT Angiography
• Ischemic Cardiomyopathy
• Non-ischemic Cardiomyopathy
• Heart Failure, Systolic
• Heart Failure，Congestive
• Heart Failure, Diastolic
• Heart Rate Low

Interventions

Type	Name	Description
DRUG	Ivabradine	7.5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 7.5 mg
DRUG	Metoprolol	5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 5 mg

Timeline

• Start date: 2018-11-26
• Primary completion: 2019-12-01
• Completion: 2019-12-01
• First posted: 2019-02-05
• Last updated: 2019-04-12

Locations

1 site across 1 country: Iran